Neuroendocrine Tumors

Neuroendocrine tumors (NETs) are a complex group of neoplasms originating from neuroendocrine cells, which are found throughout the body, especially in the digestive system and lungs. Despite being relatively rare, their incidence is rising, presenting challenges in diagnosis and treatment. Cancer research in this field aims to understand the molecular mechanisms driving NETs' development and progression, seeking novel diagnostic markers and targeted therapies. Recent advancements include the identification of specific genetic mutations and signaling pathways involved in NETs, paving the way for personalized treatment approaches. Additionally, ongoing studies explore the role of immunotherapy and combination treatments to improve outcomes for patients with advanced or metastatic disease. As research continues, the ultimate goal is to enhance early detection strategies and develop more effective therapeutic options to improve survival rates and quality of life for individuals affected by NETs.